Differences in time to disease progression do not predict for cancer-specific survival in patients receiving immediate or deferred androgen-deprivation therapy for prostate cancer: final results of EORTC randomized trial 30891 with 12 years of follo (Q52841221)
Jump to navigation
Jump to search
scientific article published on 24 July 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Differences in time to disease progression do not predict for cancer-specific survival in patients receiving immediate or deferred androgen-deprivation therapy for prostate cancer: final results of EORTC randomized trial 30891 with 12 years of follo |
scientific article published on 24 July 2013 |
Statements
Differences in time to disease progression do not predict for cancer-specific survival in patients receiving immediate or deferred androgen-deprivation therapy for prostate cancer: final results of EORTC randomized trial 30891 with 12 years of follo (English)
1 reference
Urs E Studer
1 reference
Peter Whelan
1 reference
Florian Wimpissinger
1 reference
Jacques Casselman
1 reference
Theo M de Reijke
1 reference
Hartmut Knönagel
1 reference
Wolfgang Loidl
1 reference
Santiago Isorna
1 reference
Subramanian K Sundaram
1 reference
Laurence Collette
1 reference
EORTC Genitourinary Cancer Group
1 reference
24 July 2013
1 reference
66
1 reference
5
1 reference
829-838
1 reference